Big Pharma Sharma

Big Pharma Sharma

Home
Notes
Chat
Pricing
About BPS
Sponsored Posts
Free Posts
Archive

cell therapy

The In Vivo Gold Rush: Big Pharma's $3B Cell Therapy Bet
Why Kite's entry into in vivo cell therapy marks a pivotal moment for an industry seeking to overcome the cost and scalability challenges of autologous…
 • 
Big Pharma Sharma
ESMO 2024: My Most Interesting Abstracts
Below I’ve summarized the ESMO 2024 abstracts I will be paying close attention to in September (it’s early this year!) and why data from these studies…
 • 
Big Pharma Sharma
What the Artiva IPO says about the state of cell therapy for autoimmune disease
Examining the Artiva IPO and what it means for cell therapy, B-cell driven autoimmune disease, and more
 • 
Big Pharma Sharma
ASCO 2024: Most Interesting Data Upcoming at the Conference
It's time to dive into the sea of ASCO abstracts and pick out what is most interesting
 • 
Big Pharma Sharma
AACR 2024 Most Interesting Abstract Titles
Highlighting some key abstracts to keep your eye on at AACR 2024 this April
 • 
Big Pharma Sharma
Updated Cell Therapy Autoimmune Landscape
I updated the autotimmune cell therapy landscape I put together back in November 2023 and teased out some new insights given the developments in the…
 • 
Big Pharma Sharma
A TIL-ing Odyssey Finally Ends in Approval for Iovance's AMTAGVI
Breaking down the approval of AMTAGVI and what it means for Iovance
 • 
Big Pharma Sharma
A Few Charts that Outline the Dearth of Innovation in TCR-T Cell Therapies
How much progress has the TCR-T field made in the 15+ years since Adaptimmune first entered the clinic?
 • 
Big Pharma Sharma
Big Pharma Sharma's Bullets: (Over)reacting to Recent Industry News
Some thoughts and analyses on recent news that piqued my interest
 • 
Big Pharma Sharma
AstraZeneca’s build towards becoming an immune cell therapy leader
A look back and analysis of AstraZeneca's gradual scale-up of investment in cell therapy, given the company's recent acquisition of Gracell.
 • 
Big Pharma Sharma
Everybody is in Cell Therapy Now
A put together a Cell Therapy Commitment Map to showcase the breadth and depth of development in this space. Plus, some quick takes on the…
 • 
Big Pharma Sharma
Diving into the Clinical Immune Cell Therapy Landscape for Autoimmune Diseases
I put together a development map of all clinical activity in cell therapy for autoimmune diseases and discuss key takeaways, insights, and the current…
 • 
Big Pharma Sharma
2
© 2025 Big Pharma Sharma LLC
Privacy ∙ Terms ∙ Collection notice
Start writingGet the app
Substack is the home for great culture